<DOC>
	<DOCNO>NCT00910065</DOCNO>
	<brief_summary>The objective study investigate whether intravenous administration ( injected vein ) acetylsalicylic acid ( Aspirin ) dose 250 500 mg superior oral treatment ACS tablets contain 300 mg Aspirin .</brief_summary>
	<brief_title>BAY81-8781 , I.V . Aspirin Indication Acute Coronary Syndrome ( ACS )</brief_title>
	<detailed_description>In November 2009 company 's decision cancel study international trial . However , support local MA application Aspirin i.v . indication `` For initial treatment case suspicion acute coronary syndrome '' , Bayer decide perform trial Germany domestic trial , change number participant study date .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Acetylsalicylic acid lysinate</mesh_term>
	<criteria>Angina pectoris last 20 minute within last 24 hour study drug treatment ( equivalent acute symptom increase dyspnea , diaphoresis , nausea , abdominal/epigastric pain , syncope etc . ) ECG change suggestive ischemia : ST elevation Twave change ST depression , new presume left bundlebranch block ( LBBB ) Elevated troponin T level &gt; 0.01 ng/ml , level accord local laboratory reference value Risk factor ACS know coronary artery disease ( CAD ) , diabetes mellitus , impaired renal function , peripheral artery cerebrovascular disease , current smoking . Treatment acetylsalicylic acid ( ASA ) within 48 hour prior study drug treatment Treatment glycoprotein IIa/IIIb inhibitor within 48 hour prior study drug treatment 20 minute blood sample thromboxane , prostacycline platelet aggregation measurement take Thrombolytic therapy within 24 hour study drug treatment Obligation tracheal intubation mechanical ventilation Contraindications ASA treatment Known haemorrhagic diathesis Evidence active gastrointestinal urogenital bleeding Stroke within 3 month prior study drug treatment Major surgery include coronary artery bypass graft ( CABG ) within 6 week prior study drug treatment Known severe hepatic renal insufficiency Pregnant breastfeeding woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Acute Coronary Syndrome</keyword>
	<keyword>ACS</keyword>
	<keyword>Aspirin</keyword>
</DOC>